Gemma

clinical oncologist, brachytherapist, mum of 2 and wish I had time for more…

[Gemma @eminowicz]

Delighted to be awarded best proffered paper but would not be possible without the amazing team I work with. Ebison Chinherende, Derya Yucel, @andygaya @GenesisCare

[GenesisCareUK @GenesisCare]

🎉 Congrats to Dr @eminowicz for winning Best Proffered Paper at #UKIO2025!

👏Her work on adaptive MRI-guided SABR in gynae cancers was recognised as one of the top presentations.

Oncologists: Learn more & get MRL credentialled: https://t.co/Gc3g7BBUql

[IGCS @IGCSociety]

🧪 IGCS Education360 Journal Club
📖 Featured Study: GCIG INTERLACE Trial
Explore the findings on induction chemotherapy followed by standard chemoradiotherapy vs. chemoradiotherapy alone in patients with locally advanced cervical cancer.
🎙️ With experts:
👩‍⚕️ Mary McCormack, PhD
👩‍⚕️ Gemma Eminowicz, MD
Join the conversation. Read the article and stay informed with IGCS Journal Club.
📲 https://t.co/eNDHLjG8i4

[GenesisCareUK @GenesisCare]

🎥 Curious how we're transforming gynae cancer care with MR-guided SABR? @eminowicz & Ebison Chinherende show how MR Linac tech is driving precision & adaptability in treatment. If you're a clinician wanting to drive innovation in cancer care, watch now👉🏿https://t.co/bBiJAq3AIO

[GenesisCareUK @GenesisCare]

@eminowicz @drjamesgood Ebison Chinherende, Derya Yucel

[Gemma @eminowicz]

Feeing privileged to work with such a progressive team keen to push the boundaries of patient care- expanded access for non insured UK residents now available for patients unable to have brachy boost. Please refer. @GenesisCare

[GenesisCareUK @GenesisCare]

🎉 Congrats to @eminowicz for presenting our MR-guided SABR boost pathway for gynae cancers at #UKIO2025! A leap forward in precision radiotherapy, improving outcomes when brachytherapy isn’t an option.

📥 Download poster & slides here: https://t.co/tAos2VNGRR

[Gemma @eminowicz]

So delighted for Mary McCormack being named in the Time100 health - so well deserved for tireless determination to improve the care of gynaecological cancer patients worldwide. Thank you for everything. ⁦ https://t.co/Ir2mWaxcpx

[GenesisCareUK @GenesisCare]

3,000+ cervical cancer cases are diagnosed annually in the UK. GenesisCare’s @eminowicz joined @RadChatPod to discuss MR-guided SABR as an option when brachytherapy isn’t possible. Listen here: https://t.co/JPO0WaghVx

[IPVS - International Papillomavirus Society @IPVSociety]

Cervical Cancer treatment studies show no survival advantage of chemoradiotherapy over radiotherapy alone. These results support a more selective approach, reducing unnecessary toxicity for patients with intermediate-risk cervical cancer @JAMAOnc
👉 https://t.co/4cxTGHat76

[GenesisCareUK @GenesisCare]

@eminowicz @drjamesgood #genesiscareuk

[GenesisCareUK @GenesisCare]

Join our FREE webinar on MR-guided SABR for Gynaecological Malignancies on Tuesday 29 April at 7pm. This is a great opportunity to gain valuable insights into the latest innovations in treating gynaecological malignancies.

Register here 👉🏻 https://t.co/nQ2R8rRoVN

[Gemma @eminowicz]

Great to be part of this audit pilot aiming to improve standard of care in treatment for endometrial cancer @BGCS_org @eveappeal

https://t.co/CNiQ1Os1Ki

[ESTRO @ESTRO_RT]

📢 Brachytherapy at ESTRO 2025! 🚀
From AI-driven workflows to EMBRACE II, explore the latest innovations in brachytherapy. Don’t miss insights on new tech, re-irradiation trends & its role in modern radiotherapy!

📖 Read the interview: https://t.co/gOhPwqTgli

#ESTRO25

[BGCS @BGCS_org]

Join us at the #BGCSASM2025 in London from 9-11 July. The meeting will feature two important debates from experts in the field.

View the full programme https://t.co/0deYMlpltS and register today https://t.co/7t9nHAHrVi

[Gemma @eminowicz]

Anyone looking to set up a cervix interstitial brachytherapy service join us for a 2 day hands on course at RCR

[Gemma @eminowicz]

Interested in management of locally advanced cervical cancer and recent advancements in systemic therapy as well as the EMBRACE perspective? Watch our gyn-SMART webinar

https://t.co/JM9Syk7ZRP

[Gemma @eminowicz]

Deadline fast approaching….

[Gemma @eminowicz]

https://t.co/piY12aAnvs

[John McGrane @mcgranjo777]

New @simplyoncology episode🖐️🎤🚨Talking endometrial cancer updates from this year!
Spotlight 🔦on DUO-E ?bringing PARPi into met endo ca and KEYNOTE B21 ? Pembro in adj EC space.
Check it out 👇
https://t.co/b4t9hhjxCr
@BGCS_org @ENYGO_official @GynaeCancerUK @RAINBOprogram

[John McGrane @mcgranjo777]

🚨Attention all gynae teams🚨New @simplyoncology 🎙️episode with Dr Gemma Eminowicz discussing recent conference updates in cervical cancer🎙️ INTERLACE and KN A18. Check it out👇
https://t.co/dtxTKcMj8f
@eminowicz @BGCS_org @RCObsGyn @gynoncjnls @myESMO @ENYGO_official

[Gemma @eminowicz]

Just a reminder to anyone who treats gynae cancer with radiotherapy (physicist/radiographer/clinician etc) please fill out this questionnaire to help us shape the ESTRO focus group objectives 🙏

[Gemma @eminowicz]

https://t.co/piY12aAnvs

[ESTRO @ESTRO_RT]

🔔 Two Weeks Left! Join Us at the GEC-ESTRO Brachytherapy Workshop in Hamburg! 🔔
📅 Nov 28-29, 2024
📍 Hamburg, Germany

📧 For more details or to join a satellite meeting with working group leaders, email: [email protected]

🔗 : https://t.co/dV6fx6VpVr

#ESTROGEC24 #Radonc